Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume

$0.41

0.00 (0.00%)

(As of 07/26/2024 ET)

Compare

Aptevo Therapeutics Short Interest Data

Current Short Interest: 668,300 shares
Previous Short Interest: 348,700 shares
Change Vs. Previous Month: +91.65%
Dollar Volume Sold Short: $203,965.16
Short Interest Ratio: 0.1 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 4,080,000 shares
Percentage of Shares Shorted: 16.38%
Today's Trading Volume: 465,855 shares
Average Trading Volume: 2,958,198 shares
Today's Volume Vs. Average: 16%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling Aptevo Therapeutics ?

Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

APVO Short Interest Over Time

APVO Days to Cover Over Time

APVO Percentage of Float Shorted Over Time

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Aptevo Therapeutics Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	668,300 shares	$203,965.16	+91.7%	N/A	0.1	$0.31
6/30/2024	348,700 shares	$106,702.20	+1,552.6%	N/A	0.4	$0.31
6/15/2024	21,100 shares	$16,198.47	-55.8%	0.5%	0	$0.77
5/31/2024	47,700 shares	$33,991.02	-11.7%	1.2%	0.1	$0.71
5/15/2024	54,000 shares	$43,632.00	-79.9%	1.3%	0.1	$0.81
4/30/2024	268,200 shares	$190,609.74	+84.2%	16.8%	0.3	$0.71
Get the Latest News and Ratings for APVO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	145,600 shares	$114,004.80	+324.5%	9.1%	0.6	$0.78
3/31/2024	34,300 shares	$160,867.00	+18.7%	5.1%	0.3	$4.69
3/15/2024	28,900 shares	$156,638.00	+725.7%	5.5%	0.3	$5.42
2/29/2024	3,500 shares	$26,180.00	-82.1%	N/A	0	$7.48
2/15/2024	19,600 shares	$3,077.20	+17.4%	N/A	0.1	$0.16
1/31/2024	16,700 shares	$2,715.42	-78.8%	N/A	0	$0.16
1/15/2024	78,900 shares	$12,545.10	-61.3%	N/A	0.2	$0.16
12/31/2023	203,900 shares	$36,905.90	+253.4%	N/A	0.3	$0.18
12/15/2023	57,700 shares	$9,924.40	-46.0%	N/A	0.1	$0.17
11/30/2023	106,800 shares	$19,971.60	+297.0%	N/A	0.2	$0.19
11/15/2023	26,900 shares	$4,976.50	-74.2%	N/A	0.1	$0.19
10/31/2023	104,300 shares	$29,485.61	-19.3%	N/A	0.2	$0.28
10/15/2023	129,200 shares	$41,344.00	+7.4%	N/A	0.3	$0.32
9/30/2023	120,300 shares	$39,699.00	+161.5%	N/A	0.4	$0.33
9/15/2023	46,000 shares	$18,446.00	-46.6%	N/A	0.1	$0.40
8/31/2023	86,200 shares	$37,928.00	+176.3%	N/A	0.3	$0.44
8/15/2023	31,200 shares	$11,544.00	-97.8%	N/A	0.1	$0.37
7/31/2023	1,390,000 shares	$1.45 million	+3,837.7%	N/A	5.6	$1.04
7/15/2023	35,300 shares	$52,950.00	+13.1%	N/A	0.2	$1.50
6/30/2023	31,200 shares	$45,552.00	+51.5%	N/A	0.6	$1.46
6/15/2023	20,600 shares	$32,960.00	-59.7%	N/A	0.4	$1.60
5/31/2023	51,100 shares	$79,716.00	-28.0%	N/A	1	$1.56
5/15/2023	71,000 shares	$117,150.00	-47.6%	N/A	1.3	$1.65
4/30/2023	135,500 shares	$260,160.00	+47.8%	N/A	2.4	$1.92
4/15/2023	91,700 shares	$174,230.00	-35.1%	N/A	1.6	$1.90
3/31/2023	141,200 shares	$287,342.00	+34.2%	N/A	2	$2.04
3/15/2023	105,200 shares	$190,412.00	-30.1%	N/A	1.2	$1.81
2/28/2023	150,400 shares	$318,848.00	+118.6%	N/A	0.2	$2.12
2/15/2023	68,800 shares	$141,040.00	-49.1%	N/A	0.1	$2.05
1/31/2023	135,100 shares	$310,730.00	-27.3%	N/A	0.2	$2.30
1/15/2023	185,800 shares	$418,050.00	-32.3%	N/A	0.2	$2.25
12/30/2022	274,500 shares	$636,840.00	-38.8%	N/A	0.4	$2.32
12/15/2022	448,700 shares	$1.01 million	+764.6%	N/A	0.6	$2.25
11/30/2022	51,900 shares	$161,928.00	-2.8%	N/A	1.5	$3.12
Get out of cash before the Fed's next meeting (Ad) "How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains." Click here now to watch this exclusive interview
11/15/2022	53,400 shares	$178,890.00	-12.3%	N/A	1.5	$3.35
10/31/2022	60,900 shares	$183,918.00	+6.8%	N/A	1.3	$3.02
10/15/2022	57,000 shares	$161,310.00	+8.6%	N/A	0.9	$2.83
9/30/2022	52,500 shares	$159,600.00	+23.8%	N/A	0.9	$3.04
9/15/2022	42,400 shares	$158,576.00	+3.9%	N/A	0.7	$3.74
8/31/2022	40,800 shares	$144,432.00	-4.5%	N/A	0.4	$3.54
8/15/2022	42,700 shares	$195,993.00	-48.9%	N/A	0.5	$4.59
7/31/2022	83,500 shares	$328,990.00	-9.3%	N/A	1	$3.94
7/15/2022	92,100 shares	$361,032.00	-30.2%	N/A	1.3	$3.92
6/30/2022	132,000 shares	$472,560.00	-24.8%	N/A	1.4	$3.58
6/15/2022	175,600 shares	$579,480.00	+20.9%	N/A	0.8	$3.30
5/31/2022	145,200 shares	$665,016.00	+1.0%	N/A	0.7	$4.58
5/15/2022	143,700 shares	$661,020.00	-13.4%	N/A	0.7	$4.60
4/30/2022	165,900 shares	$706,734.00	-12.2%	N/A	0.7	$4.26
4/15/2022	188,900 shares	$899,164.00	-6.3%	N/A	0.7	$4.76
3/31/2022	201,600 shares	$1.18 million	+39.5%	N/A	0.8	$5.87
3/15/2022	144,500 shares	$647,360.00	+1.4%	N/A	1	$4.48
2/28/2022	142,500 shares	$820,800.00	-19.4%	N/A	0.6	$5.76
2/15/2022	176,800 shares	$1.11 million	+247.4%	N/A	0.1	$6.29
1/31/2022	50,900 shares	$297,256.00	-65.8%	N/A	0	$5.84
1/15/2022	148,600 shares	$1.07 million	-35.3%	N/A	0	$7.22
12/31/2021	229,500 shares	$1.81 million	-25.8%	N/A	0.1	$7.87
12/15/2021	309,400 shares	$2.44 million	-72.4%	N/A	0.1	$7.90
11/30/2021	1,120,000 shares	$11.16 million	+1,182.9%	N/A	0.3	$9.96
11/15/2021	87,300 shares	$848,556.00	+4.9%	N/A	0	$9.72
10/29/2021	83,200 shares	$1.27 million	+32.3%	N/A	1.6	$15.24
10/15/2021	62,900 shares	$942,871.00	+4.7%	N/A	1.4	$14.99
9/30/2021	60,100 shares	$927,944.00	-6.1%	N/A	1.2	$15.44
9/15/2021	64,000 shares	$1.10 million	-13.9%	N/A	1.2	$17.14
8/31/2021	74,300 shares	$1.33 million	-20.8%	N/A	1	$17.95
8/13/2021	93,800 shares	$1.59 million	-1.7%	N/A	1.2	$17.00
7/30/2021	95,400 shares	$1.79 million	-9.2%	2.3%	1.3	$18.77
7/15/2021	105,100 shares	$1.87 million	-5.0%	2.5%	1.4	$17.75
6/30/2021	110,600 shares	$2.48 million	+5.2%	2.7%	1.5	$22.43
6/15/2021	105,100 shares	$3.15 million	-10.0%	2.5%	1.6	$30.00
5/28/2021	116,800 shares	$3.05 million	+15.3%	2.8%	2.5	$26.12
5/14/2021	101,300 shares	$2.22 million	-24.7%	2.4%	2.5	$21.93
4/30/2021	134,600 shares	$3.68 million	+1.4%	3.2%	2.9	$27.34
4/15/2021	132,800 shares	$3.40 million	-9.8%	3.3%	2.5	$25.57
3/31/2021	147,300 shares	$4.15 million	-19.8%	3.6%	2.3	$28.20
3/15/2021	183,600 shares	$6.60 million	-8.4%	4.6%	2.6	$35.97
2/26/2021	200,500 shares	$6.34 million	+21.0%	5.0%	2.6	$31.62
2/12/2021	165,700 shares	$6.09 million	+19.1%	4.1%	1.7	$36.76
1/29/2021	139,100 shares	$4.84 million	+11.0%	3.5%	0.2	$34.83
1/15/2021	125,300 shares	$4.24 million	-18.1%	3.1%	0.1	$33.82
12/31/2020	153,000 shares	$5.68 million	-7.7%	3.8%	0.1	$37.11
12/15/2020	165,800 shares	$6.90 million	-40.1%	4.2%	0.1	$41.61
11/30/2020	276,700 shares	$12.28 million	-71.0%	7.5%	0.2	$44.39
11/15/2020	955,400 shares	$42.97 million	+999.4%	25.9%	0.6	$44.98
10/30/2020	86,900 shares	$572,671.00	+2.4%	3.0%	0.1	$6.59
Get out of cash before the Fed's next meeting (Ad) "How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all $20,000 of his wife's 401k into shares of just ONE stock. Everyone on Wall Street said he was crazy. But a year later, that $20,000 in his wife's account was worth $120,000. Today, he says: "If you thought the dot-com mania was intense, what's about to happen in the coming weeks could be even crazier and could open up a new window of opportunity for 500%-plus gains." Click here now to watch this exclusive interview
10/15/2020	84,900 shares	$594,300.00	-15.1%	3.0%	1.6	$7.00
9/30/2020	100,000 shares	$760,000.00	+33.7%	3.5%	1.2	$7.60
9/15/2020	74,800 shares	$596,156.00	+9.2%	2.6%	0.1	$7.97
8/31/2020	68,500 shares	$537,040.00	-20.3%	2.4%	0.1	$7.84
8/14/2020	85,900 shares	$684,623.00	+39.7%	3.0%	0.1	$7.97
7/31/2020	61,500 shares	$516,600.00	+27.6%	2.1%	0.1	$8.40
7/15/2020	48,200 shares	$352,342.00	-75.1%	1.7%	0.1	$7.31
6/30/2020	193,600 shares	$1.62 million	+147.6%	6.7%	0.3	$8.35
6/15/2020	78,200 shares	$420,716.00	-0.4%	2.7%	0.8	$5.38
5/29/2020	78,500 shares	$466,290.00	-3.8%	2.7%	0.6	$5.94
5/15/2020	81,600 shares	$446,352.00	+54.0%	2.8%	0.6	$5.47
4/30/2020	53,000 shares	$265,000.00	-8.5%	1.8%	0.4	$5.00
4/15/2020	57,900 shares	$242,022.00	+2.1%	2.0%	0.7	$4.18
3/31/2020	56,700 shares	$242,676.00	-93.8%	2.0%	0.7	$4.28
3/13/2020	918,900 shares	$3.53 million	-44.3%	2.3%	0.3	$3.84
2/28/2020	1,650,000 shares	$429,000.00	+36.4%	4.1%	2.8	$0.26
2/14/2020	1,210,000 shares	$435,600.00	+10.0%	3.0%	2.9	$0.36
1/31/2020	1,100,000 shares	$484,000.00	-26.7%	2.7%	2.9	$0.44
1/15/2020	1,500,000 shares	$765,000.00	-10.7%	3.7%	4.1	$0.51
12/31/2019	1,680,000 shares	$1.08 million	-2.9%	4.2%	4.7	$0.64

APVO Short Interest - Frequently Asked Questions

What is Aptevo Therapeutics' current short interest?: Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 668,300 shares of APVO short. Learn More on Aptevo Therapeutics' current short interest.
Which institutional investors are shorting Aptevo Therapeutics?: As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptevo Therapeutics: Concourse Financial Group Securities Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.
Is Aptevo Therapeutics' short interest increasing or decreasing?: Aptevo Therapeutics saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 668,300 shares, an increase of 91.7% from the previous total of 348,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does Aptevo Therapeutics' short interest compare to its competitors?: Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aptevo Therapeutics: Galera Therapeutics, Inc. (5.49%), Xenetic Biosciences Inc (0.05%), Tenax Therapeutics, Inc. (1.28%), Notable Labs, Ltd. (5.72%), Kazia Therapeutics Limited (20.69%), Bionomics Limited (1.82%), FSD Pharma Inc. (0.12%), GeoVax Labs, Inc. (5.29%), Alaunos Therapeutics, Inc. (9.66%), Pasithea Therapeutics Corp. (0.55%),

Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.
What does it mean to sell short Aptevo Therapeutics stock?: Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Aptevo Therapeutics?: A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further.
How often is Aptevo Therapeutics' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is July, 15 2024.